Private Equity
The Universities Superannuation Scheme (USS) has hired Robin Filmer-Wilson as it plans to increase its co-investment activity.
2 min read · 21 September 2013
Chile’s ‘sophisticated’ pensions may be LPs in Oaktree Capital Managements next round of funds, says managing partner John Frank.
2 min read · 21 September 2013
Sellers’ concerns with proposed increases to the capital gains rate may have led to a spike in US private equity deal activity during the fourth quarter.
2 min read · 21 September 2013
The UK mid-market firm has sold Rosemont Pharmaceuticals to a US trade buyer for £180m – having more than doubled EBITDA during its period of ownership.
2 min read · 21 September 2013
The pharmaceutical royalties-focused firm aims to hold a final close on $1bn by the end of the first quarter.
2 min read · 21 September 2013
The global alternative asset manager has appointed Niel Thassim as head of Asia for its Private Funds Group to drive fundraising for private investment vehicles across its asset classes.
2 min read · 21 September 2013
Andrew Sheiner's Altas Partners has hired Scott Werry from Providence Equity Partners, bringing the Altas team to seven individuals.
2 min read · 21 September 2013
Unlike its predecessor fund, DB Secondary Opportunities Fund II targeted US investors, which make up 40% of the fund commitments.
2 min read · 21 September 2013
The $967m sale of plastic equipment maker Mold-Masters has delivered a good exit for the UK-listed firm, after a subdued 2012 – and it hopes there are more to come.
2 min read · 21 September 2013
Andrew Caspersen will focus on the growing need of GPs to restructure aging funds that are approaching the end of their lives.
4 min read · 21 September 2013
